Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa
The DOI matches its Crossref record; 25 of the 27 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine the burden and impact of immune reconstitution disease (IRD) associated with tuberculosis (TB) among patients initiating antiretroviral treatment (ART) in sub-Saharan Africa. DESIGN: Retrospective analysis of a study cohort enrolled over 3 years within a community-based ART service in South Africa. METHODS: Patients receiving treatment for TB at the time ART was initiated (n = 160) were studied. Cases of TB-associated IRD during the first 4 months of ART were ascertained. RESULTS: The median baseline CD4 cell count was 68 cells/microl [interquartile range (IQR), 29-133 cells/microl) and ART was initiated after a median of 105 days (IQR, 61-164 days) from TB diagnosis. Although IRD was diagnosed in just 12% (n = 19) of patients overall, IRD developed in 32% (n = 12) of those who started ART within 2 months of TB diagnosis. Pulmonary involvement was observed in 84% (n = 16) and intra-abdominal manifestations were also common (37%). Overall, 4% (n = 7) of the cohort required secondary level health-care for IRD and two (1%) patients died. In multivariate analysis, risk of IRD was strongly associated with early ART initiation and low baseline CD4 cell count. Of patients with CD4 counts < 50 cells/microl, the proportions who developed IRD following initiation of ART within 0-30, 31-60, 61-90, 91-120 and > 120 days of TB diagnosis were 100%, 33%, 14%, 7% and 0%, respectively. CONCLUSIONS: The risk of TB-associated IRD in this setting is very high for those with low baseline CD4 cell counts initiating ART early in the course of antituberculosis treatment. However, most cases were self-limiting; overall secondary health-care utilization and mortality risk from IRD were low.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, HIV-positive patients with apparent sole pulmonary tuberculosis may develop peripheral or central lymphadenitis as the manifestation of IRIS [58].”
From Current diagnosis and management of peripheral tuberculous lymphadenitis. (2011) · cites this paper as [58]
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
The Growing Burden of Tuberculosis: Global Trends and Interactions With the HIV Epidemic
Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C., & Dye, C. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1009 · Cited by 2,553 · cited 1×
“A majority of the global burden of HIV-associated tuberculosis (TB) lies in sub-Saharan Africa [1] and rates in southern Africa have reached almost unprecedented”
BackgroundTuberculosis in Patients with Human Immunodeficiency Virus Infection
Havlir, D. V., & Barnes, P. F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902043400507 · Cited by 1,461 · cited 1×
“Moreover, the risks associated with TB-IRD are important variables in the debate over the optimal time for ART initiation in patients with TB [7,8,10].”
BackgroundShelburne, S. A., Visnegarwala, F., Darcourt, J., Graviss, E. A., Giordano, T. P., White, A. C., & Hamill, R. J. (2005) · AIDS · doi:10.1097/01.aids.0000161769.06158.8a · Cited by 632 · cited 3×
“In common with most previous studies [9,19,20,22,23], diagnoses of IRD were made retrospectively but were nevertheless based on systematically collected prospective data.”
BackgroundParadoxical Worsening of Tuberculosis Following Antiretroviral Therapy in Patients with AIDS
NARITA, M., ASHKIN, D., HOLLENDER, E. S., & PITCHENIK, A. E. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.1.9712001 · Cited by 608 · cited 2×
“patients attending referral hospitals [9,20,21,23].”
ResultLawn, S. D., Bekker, L.-G., & Miller, R. F. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70140-7 · Cited by 545 · cited 7×
“Moreover, the risks associated with TB-IRD are important variables in the debate over the optimal time for ART initiation in patients with TB [7,8,10].”
BackgroundMethodInfluentialSelf-citationParadoxical reactions during tuberculosis treatment in patients with and without HIV co-infection
Breen, R. A. M. (2004) · Thorax · doi:10.1136/thx.2003.019224 · Cited by 367 · cited 4×
“In common with most previous studies [9,19,20,22,23], diagnoses of IRD were made retrospectively but were nevertheless based on systematically collected prospective data.”
BackgroundInfluentialLawn, S. D., Myer, L., Bekker, L.-G., & Wood, R. (2006) · AIDS · doi:10.1097/01.aids.0000238406.93249.cd · Cited by 363
Self-citationLawn, S. D., Myer, L., Orrell, C., Bekker, L.-G., & Wood, R. (2005) · AIDS · doi:10.1097/01.aids.0000194802.89540.e1 · Cited by 359 · cited 3×
“reported that cryptococcal IRD is a far more common cause of death in this service [12,15].”
BackgroundMethodResultSelf-citationTreatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy
Dean, G. L., Edwards, S. G., Ives, N. J., Matthews, G., Fox, E. F., Navaratne, L., Fisher, M., Taylor, G. P., Miller, R., Taylor, C. B., et al. (2002) · AIDS · doi:10.1097/00002030-200201040-00010 · Cited by 354
Cited by
Items 101–200 of 346
Immune reconstitution inflammatory syndrome after highly active antiretroviral therapy: a review
Tsang, C. S. P., & Samaranayake, L. P. (2010) · Oral Diseases · doi:10.1111/j.1601-0825.2009.01628.x · Cited by 45
Lawn, S. D. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3282a6463d · Cited by 42
Self-citationGeng, E., Glidden, D. V., Bangsberg, D. R., Bwana, M. B., Musinguzi, N., Nash, D., Metcalfe, J. Z., Yiannoutsos, C. T., Martin, J. N., & Petersen, M. L. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr444 · Cited by 46
Worodria, W. O., Menten, J., Loembé, M. M., Mazakpwe, D., Bagenda, D. S., Koole, O., Mayanja‐Kizza, H., Kestens, L., Mugerwa, R. D., Reiss, P., et al. (2012) · Antiviral Therapy · doi:10.3851/imp2108 · Cited by 43
“This is a higher proportion of TB-IRIS than has been previously reported from resource-limited countries with a high TB and HIV burden [14,21,22].”
BackgroundInvestigation Outcomes of Tuberculosis Suspects in the Health Centers of Addis Ababa, Ethiopia
Deribew, A., Negussu, N., Melaku, Z., & Deribe, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018614 · Cited by 40
“In patients starting antiretroviral therapy, undiagnosed TB is common and carries a substantially increased risk of death or hospitalization in the first few months of treatment [14,15].”
BackgroundTieu, H., Ananworanich, J., Avihingsanon, A., Apateerapong, W., Sirivichayakul, S., Siangphoe, U., Klongugkara, S., Boonchokchai, B., Hammer, S. M., & Manosuthi, W. (2009) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2009.0055 · Cited by 43
“84 Opportunistic and coinfections, n (%) Hepatitis B 9 (7) 1 (5) 8 (8) Hepatitis C 29 (23) 4 (2) 25 (24) Prior TB 5 (4) 2 (9) 3 (3) Cryptococcosis 3 (2) 0 (0) 3 (3) Pneumocystis jirovecii pneumonia 7 (6) 1 (5) 6 (6) Oral=esophageal candidiasis 49 (39) 13 (59) 36 (35) 0.”
Timing of Antiretroviral Therapy for HIV in the Setting of TB Treatment
Piggott, D. A., & Karakousis, P. C. (2010) · Clinical and Developmental Immunology · doi:10.1155/2011/103917 · Cited by 44
“44 per 100 person months in the late arm), consistent with the findings of previous studies regarding the development of IRIS relative to HAART initiation [63–66].”
ResultManosuthi, W., Tieu, H., Mankatitham, W., Lueangniyomkul, A., Ananworanich, J., Avihingsanon, A., Siangphoe, U., Klongugkara, S., Likanonsakul, S., Thawornwan, U., et al. (2009) · AIDS · doi:10.1097/qad.0b013e32832f7b59 · Cited by 46
“ranged from 8 to 13% [6,7,9] compared with 17 to 43% from resource-rich countries [10–14].”
BackgroundAntiretroviral Outcomes in South African Prisoners: A Retrospective Cohort Analysis
Davies, N., & Karstaedt, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033309 · Cited by 39
“As reported elsewhere, ARTassociated TB IRIS was most common when ART was initiated within one month of TB treatment commencing [51].”
BackgroundTuberculosis and HIV Co-Infection: Screening and Treatment Strategies
Venkatesh, K. K., Swaminathan, S., Andrews, J. R., & Mayer, K. H. (2011) · Drugs · doi:10.2165/11591360-000000000-00000 · Cited by 41
“[40] HIV-infected individuals with smear-negative disease have a higher mortality rate relative to HIV-infected individuals with smear-positive TB, as well as HIV-uninfected individuals with smear-negative TB.[41] It is also important to note that drug susceptibilities cannot be ascertained by smear microscopy, so tre…”
BackgroundInfluentialDeps, P. D., & Lockwood, D. N. J. (2010) · Leprosy Review · doi:10.47276/lr.81.1.59 · Cited by 36
Krentz, H. B., & Gill, M. J. (2008) · Health Policy · doi:10.1016/j.healthpol.2008.09.016 · Cited by 35
Cutaneous manifestations of immune reconstitution inflammatory syndrome
Huiras, E. E., Preda, V. A., Maurer, T. A., & Whitfeld, M. J. (2008) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328302cefe · Cited by 34
Lawn, S. D., Fraenzel, A., Kranzer, K., Caldwell, J., Bekker, L., & Wood, R. (2011) · South African Medical Journal · doi:10.7196/samj.4392 · Cited by 34
Self-citationImmune Reconstitution Inflammatory Syndrome (IRIS): What pathologists should know
Nelson, A. M., Manabe, Y. C., & Lucas, S. B. (2017) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2017.04.010 · Cited by 40
“Table 2 lists other reported infections and Table 3 lists non-infections conditions related to IRIS (13, 17, 23-57).”
Podzamczer, D. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13123842 · Cited by 38
Respiratory infection complicating HIV infection
Davis, J. L., Fei, M., & Huang, L. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3282f54fff · Cited by 34
Agarwal, U., Kumar, A., Behera, D., French, M. A., & Price, P. (2012) · AIDS Research and Therapy · doi:10.1186/1742-6405-9-17 · Cited by 34
“Understanding of this phenomenon is particularly relevant for HIV clinics in South East Asia and Africa where many patients with active TB enter ART programs [1,7].”
BackgroundInfluentialWijting, I. E. A., Wit, F. W. N. M., Rokx, C., Leyten, E. M. S., Lowe, S. H., Brinkman, K., Bierman, W. F. W., van Kasteren, M. E. E., Postma, A. M., Bloemen, V. C. M., et al. (2019) · EClinicalMedicine · doi:10.1016/j.eclinm.2019.11.003 · Cited by 34
Satti, H., McLaughlin, M., Omotayo, D. B., Keshavjee, S. A., Becerra, M. C., Mukherjee, J. S., & Seung, K. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037114 · Cited by 33
“There were no incidences of immune reconstitution inflammatory syndrome (IRIS) after ART initiation.”
InfluentialCritical Illness in HIV-Infected Patients in the Era of Combination Antiretroviral Therapy
Akgün, K. M., Huang, L., Morris, A., Justice, A. C., Pisani, M. A., & Crothers, K. A. (2011) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201009-060wr · Cited by 36
“Risk factors for IRIS include starting ART in close proximity to treatment for an acute opportunistic infection (60, 61), lower CD4 cell counts at the time of ART initiation (61, 62), rapid decline in HIV RNA after initiation of ART, and the use of boosted protease inhibitors (these inhibit intestinal and hepatic meta…”
BackgroundParadoxical Reactions and the Immune Reconstitution Inflammatory Syndrome
Church, L. W. P., Chopra, A., & Judson, M. A. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.tnmi7-0033-2016 · Cited by 40
Genotype assays and third-line ART in resource-limited settings
Lorenzana, S. B., Hughes, M. D., Grinsztejn, B. G. J., Collier, A. C., Luz, P. M., Freedberg, K. A., Wood, R., Levison, J. H., Mugyenyi, P. N., Salata, R. A., et al. (2012) · AIDS · doi:10.1097/qad.0b013e32835221eb · Cited by 33
“Over 40% of the cohort has HIV RNA above 100 000 copies/ml [41].”
BackgroundSelf-citationde Menezes, V. M., Sales, A. M., Illarramendi, X., Miranda, A. M., Morgado, M. G., Gutierrez‐Galhardo, M. C., Sarno, E. N., & Nery, J. A. D. C. (2009) · AIDS · doi:10.1097/qad.0b013e3283291405 · Cited by 32
Browne, S. H., Barford, K., Ramela, T., & Dowse, R. (2018) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2018.05.012 · Cited by 32
Pulmonary complications of immune reconstitution inflammatory syndromes in HIV‐infected patients
Crothers, K. A., & Huang, L. (2009) · Respirology · doi:10.1111/j.1440-1843.2008.01468.x · Cited by 32
Pulmonary manifestations of the immune reconstitution inflammatory syndrome
Calligaro, G., Meintjes, G., & Mendelson, M. (2011) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328344f692 · Cited by 31
Link‐Gelles, R., Moultrie, H., Sawry, S., Murdoch, D. M., & Rie, A. V. (2013) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000142 · Cited by 31
Lawn, S. D., Campbell, L. J., Kaplan, R., Boulle, A., Cornell, M., Kerschberger, B., Morrow, C. D., Little, F., Egger, M., & Wood, R. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182199ee9 · Cited by 31
Self-citationRavimohan, S., Tamuhla, N., Steenhoff, A. P., Letlhogile, R., Makutu, D. K., Nfanyana, K., Rantleru, T., Tierney, A. M., Nkakana, K., Schwartz, A. B., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit368 · Cited by 33
Karmakar, S., Sharma, S. K., Vashishtha, R., Sharma, A., Ranjan, S., Gupta, D., Sreenivas, V., Sinha, S., Biswas, A., & Gulati, V. (2010) · Clinical and Developmental Immunology · doi:10.1155/2011/239021 · Cited by 32
“[13–28].”
InfluentialFranke, M. F., Robins, J. M., Mugabo, J., Kaigamba, F., Cain, L. E., Fleming, J. G., & Murray, M. B. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001029 · Cited by 31
“This uncertainty has posed a major challenge for clinicians, who often defer cART in individuals initiating TB treatment because of concern about immune reconstitution inflammatory syndrome (IRIS) [1–5], the possibility of drug interactions [6] and adverse side effects [7], and the risk of reduced adherence due to a h…”
BackgroundChandrasekhar, A., & Gupta, A. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.019018 · Cited by 30
“In our review, we assessed both single and multiple micronutrient studies to more broadly assess the impact of nutrient supplementation on HIV disease progression pre- and post-HAART initiation.”
BackgroundInfluentialBisson, G. P., Zetola, N. M., & Collman, R. G. (2015) · Current HIV/AIDS Reports · doi:10.1007/s11904-015-0256-x · Cited by 32
Extensively Drug-resistant Tuberculosis
Madariaga, M. G., Lalloo, U., & Swindells, S. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.04.015 · Cited by 42
Sharma, S. K., Dhooria, S., Barwad, P. W., Kadhiravan, T., Ranjan, S., Miglani, S., & Gupta, D. (2010) · PubMed · Cited by 36
Abnormal Tryptophan Metabolism in HIV and Mycobacterium tuberculosis Infection
Wang, X., Mehra, S., Kaushal, D., Veazey, R. S., & Xu, H. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.666227 · Cited by 32
“Although ART in HIV/Mtb coinfected patients reduces opportunistic infections and enhances Mtbspecific T cell responses, it may not ameliorate TB diseases due to the paradoxical immune reconstitution inflammatory syndrome (IRIS) (Manosuthi et al., 2006; Lawn et al., 2007; Meintjes et al., 2008; Elliott et al., 2009; Na…”
BackgroundBonnet, M., Baudin, E., Jani, I. V., Nunes, E. A., Verhoustraeten, F., Calmy, A., Bastos, R., Bhatt, N., & Michon, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084585 · Cited by 29
“Low CD4 cell count at ART initiation and short time interval between starting TB therapy and ART were the best predictors of paradoxical TB-associated IRIS [11-13].”
BackgroundResultKerkhoff, A. D., Wood, R., Lowe, D. M., Vogt, M., & Lawn, S. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067956 · Cited by 30
“Patient Characteristics The community-based antiretroviral therapy (ART) service in Gugulethu township in Cape Town, South Africa and the burden of TB among its patients have been previously described in detail [12–15].”
BackgroundSelf-citationLawn, S. D., Myer, L., Bangani, N., Vogt, M., & Wood, R. (2007) · BMC Infectious Diseases · doi:10.1186/1471-2334-7-41 · Cited by 29
Self-citationEshun‐Wilson, I., Havers, F. P., Nachega, J. B., Prozesky, H. W., Taljaard, J., Zeier, M., Cotton, M. F., Simon, G. L., & Soentjens, P. H. P. (2010) · Journal of the International Association of Physicians in AIDS Care · doi:10.1177/1545109710361537 · Cited by 33
Initiating antiretrovirals during tuberculosis treatment: a drug safety review
Gengiah, T. N., Gray, A. L., Naidoo, K., & Karim, Q. A. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.546783 · Cited by 32
“Mortality rates from TB IRIS have been reported in the literature and in most instances are low [113,116,117].”
Shao, H. J., Crump, J. A., Ramadhani, H. O., Uiso, L. O., Ole-Nguyaine, S., Moon, A. M., Kiwera, R. A., Woods, C. W., Shao, J. F., Bartlett, J. A., et al. (2009) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2009.0100 · Cited by 29
“The risk of immune reconstitution inflammatory syndromes is greater among patients with lower baseline CD4 cell counts, 7,10,14 and the median baseline count in the THIRST subjects was 104 cells = mm 3 .”
Meintjes, G., Lawn, S. D., Scano, F., Maartens, G., Worodria, W. O., Murdoch, D. M., Wilkinson, R. J., Seyler, C., John, L., van der Loeff, M. F. S., et al. (2008) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/p2xt-q966 · Cited by 28
Self-citationThe Immune Interaction between HIV-1 Infection andMycobacterium tuberculosis
Bruyn, E. D., & Wilkinson, R. J. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0012-2016 · Cited by 35
“Risk factors for paradoxical IRIS include low pre-ART CD4, with rapid reconstitution following ART initiation (241, 242), high pre-ART viral load (243), extrapulmonary TB (244, 245), and a short time interval between starting ATT and ART initiation (244, 246).”
BackgroundInfluentialHartigan-O’Connor, D. J., Jacobson, M. A., Tan, Q. X., & Sinclair, E. (2010) · Clinical Infectious Diseases · doi:10.1093/cid/ciq112 · Cited by 27
“The symptoms of IRIS are often localized to sites of previous infection [3], and IRIS in patients with a history of cytomegalovirus retinitis (CMVR) can manifest as in-flammation of the posterior uveal tract of the eye [4].”
BackgroundWester, C. W., Bussmann, H., Koethe, J. R., Moffat, C., Vermund, S. H., Essex, M., & Marlink, R. (2009) · HIV Therapy · doi:10.2217/hiv.09.35 · Cited by 30
Munderi, P., Walker, A. S., Kityo, C. M., Babiker, A. G., Ssali, F. N., Reid, A., Darbyshire, J. H., Grosskurth, H., Mugyenyi, P. N., Gibb, D. M., et al. (2010) · HIV Medicine · doi:10.1111/j.1468-1293.2009.00786.x · Cited by 26
Chelkeba, L., Fekadu, G., Umeta, G. T., Belayneh, F., Melaku, T., & Mekonnen, Z. (2020) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2020.05.004 · Cited by 26
Strategies to optimize HIV treatment outcomes in resource-limited settings.
Nakanjako, D., Colebunders, R., Coutinho, A., & Kamya, M. R. (2009) · PubMed · Cited by 28
Otwombe, K. N., Variava, E., Holmes, C. B., Chaisson, R. E., & Martinson, N. A. (2013) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0891 · Cited by 26
A pilot metabolomics study of tuberculosis immune reconstitution inflammatory syndrome
Silva, C. A. M., Graham, B., Webb, K. J., Ashton, L. V., Harton, M. R., Luetkemeyer, A. F., Bokatzian, S. S., Al-Mubarak, R., Mahapatra, S., Hovind, L., et al. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.04.015 · Cited by 28
“61) and there was no evidence of sex influence in the development of TB-IRIS (Karmakar et al., 2011; Lawn et al., 2007).”
BackgroundIntegration and Task Shifting for TB/HIV Care and Treatment in Highly Resource-Scarce Settings
Rie, A. V., Patel, M. R., Nana, M., Driessche, K. V., Tabala, M., Yotebieng, M., & Behets, F. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000434954.65620.f3 · Cited by 26
Pathai, S., Gilbert, C. E., Weiss, H. A., McNally, M., & Lawn, S. D. (2011) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2010.02712.x · Cited by 27
“We studied two comparable cohorts of patients initiating antiretroviral therapy in Mumbai, India, and Cape Town, South Africa.”
MethodSelf-citationPrevention and treatment of the immune reconstitution inflammatory syndrome
Meintjes, G., & Lynen, L. (2008) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3282fe6e84 · Cited by 28
Impact of Antiretroviral Therapy on Lung Immunology and Inflammation
Twigg, H. L., & Knox, K. S. (2013) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.01.004 · Cited by 25
The Case for Integrating Tuberculosis and HIV Treatment Services in South Africa
Wood, R. (2007) · The Journal of Infectious Diseases · doi:10.1086/521118 · Cited by 24
Self-citationLee, S. S., Meintjes, G., Kamarulzaman, A., & Leung, C. C. (2013) · Respirology · doi:10.1111/resp.12120 · Cited by 26
Antiretroviral therapy in Indian setting: When & what to start with, when & what to switch to?
Kumarasamy, N., Pujari, S. N., & Patel, A. K. (2011) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.92626 · Cited by 31
Immune Reconstitution Inflammatory Syndrome
Beatty, G. W. (2010) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2010.01.004 · Cited by 26
“Between 5% and 40% of cases involve intraabdominal manifestations.(6,28,32) CNS involvement, including tuberculosis abscesses and meningitis, occur in about 5% to 12% of cases and are of particular concern, given the attendant risk for neurologic deterioration.”
BackgroundNaidoo, K., Naidoo, K., Padayatchi, N., & Karim, Q. A. (2010) · Clinical and Developmental Immunology · doi:10.1155/2011/585919 · Cited by 31
“A South African study indicated a 12% overall incidence of TB IRIS in HIV-TB co-infected patients, with an IRIS incidence of 32% when ART was initiated within 2 months of TB diagnosis and an IRIS incidence of 70% if ART was initiated within a month of starting TB therapy [51].”
BackgroundLeprosy after starting antiretroviral treatment
Lawn, S. D., & Lockwood, D. N. J. (2007) · BMJ · doi:10.1136/bmj.39107.480359.80 · Cited by 24
Self-citationRajasekaran, S., Raja, K., Jeyaseelan, L., Vijilat, S., Priya, K. B., Mohan, K., Parvez, A., Mahilmaran, A., & Chandrasekar, C. (2009) · PubMed · Cited by 22
Management of Advanced HIV Disease
Summers, N. A., & Armstrong, W. S. (2019) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2019.05.005 · Cited by 22
Lawn, S. D., & French, M. A. (2007) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3281a3c0a6 · Cited by 24
Self-citationLawn, S. D., & Wood, R. (2007) · PubMed · Cited by 21
Self-citationAljohaney, A. A., Amjadi, K., & Alvarez, G. G. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/842045 · Cited by 21
Is vitamin D deficiency involved in the immune reconstitution inflammatory syndrome?
Conesa-Botella, A., Mathieu, C., Colebunders, R., Moreno‐Reyes, R., van Etten, E., Lynen, L., & Kestens, L. (2009) · AIDS Research and Therapy · doi:10.1186/1742-6405-6-4 · Cited by 25
“Implication of the hypothesis There is an inter-relationship between vitamin D metabolism, HAART therapy and immunity.”
InfluentialSyndrome inflammatoire de reconstitution immune
Breton, G. (2010) · médecine/sciences · doi:10.1051/medsci/2010263281 · Cited by 22
“Un taux de lymphocytes T CD4 inférieur à 50-100/mm3 [26-28] dans le contexte d’infections VIH compliquées ou non de tuberculose, une lymphopénie globale dans celui de tuberculoses hors du contexte d’une infection VIH [29], ou encore la sévérité (taux de polynucléaires neutrophiles inférieur à 100/ mm3) et la durée de…”
Tuberculosis burden on AIDS in Brazil: A study using linked databases
Saraceni, V., Benzaken, A. S., Pereira, G. F. M., Andrade, K. B., Oliveira, P. B., Arakaki-Sánchez, D., Caruso, A., & de Souza, F. M. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207859 · Cited by 20
Current Medical Management of Pulmonary Tuberculosis
Belknap, R. (2018) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2018.09.004 · Cited by 20
New drugs and regimens for treatment of TB
Leibert, E. M., & Rom, W. N. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.60 · Cited by 24
Hepatic involvement with tuberculosis-associated immune reconstitution disease
Lawn, S. D., & Wood, R. (2007) · AIDS · doi:10.1097/qad.0b013e3282f1be39 · Cited by 20
Self-citationLater onset of herpes zoster‐associated immune reconstitution inflammatory syndrome
Espinosa, E., Peña‐Jiménez, Á., Ormsby, C. E., Vega-Barrientos, R. S., & Reyes‐Terán, G. (2009) · HIV Medicine · doi:10.1111/j.1468-1293.2009.00700.x · Cited by 19
Tuberculosis-immune reconstitution inflammatory syndrome in HIV: from pathogenesis to prediction
Narendran, G., Andrade, B. B., & Swaminathan, S. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.892828 · Cited by 20
“Shorter ATT–ART interval coupled with shorter duration of TB treatment at ART initiation is a credible predictor, which provides a conducive environment for IRIS occurrence [4,5,21].”
BackgroundImmune Reconstitution Inflammatory Syndrome in a Resource-Poor Setting
Klotz, S. A., Mohammed, A. A., Mulugeta, G. W., Mitku, M. W., & Handrich, M. (2009) · Journal of the International Association of Physicians in AIDS Care · doi:10.1177/1545109709332469 · Cited by 19
Updates in the Treatment of Active and Latent Tuberculosis
Belknap, R., & Haas, M. K. (2018) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0038-1660863 · Cited by 22
Espinosa, E., Ormsby, C. E., Vega-Barrientos, R. S., Ruiz‐Cruz, M., Moreno‐Coutiño, G., Peña‐Jiménez, Á., Peralta-Prado, A., Cantoral-Díaz, M.-T., Romero‐Rodríguez, D. P., & Reyes‐Terán, G. (2010) · International Journal of STD & AIDS · doi:10.1258/ijsa.2010.010135 · Cited by 27
Immune reconstitution disease associated with mycobacterial infections
Lawn, S. D., Lipman, M. C. I., & Easterbrook, P. (2008) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3282fe99dc · Cited by 20
Self-citationTuberculosis Drug Development: Ensuring People Living with HIV Are Not Left Behind
Luetkemeyer, A. F., Getahun, H., Chamie, G., Lienhardt, C., & Havlir, D. V. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201106-0995pp · Cited by 19
“A high frequency of TB paradoxical reactions or IRIS has been reported in patients with TB/HIV when compared with HIVuninfected patients (41).”
ResultHanekom, W. A., Lawn, S. D., Dheda, K. U. J., & Whitelaw, A. C. (2010) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2010.02568.x · Cited by 22
“Although deaths associated with TB-IRD have been reported, it is evident that the contribution of such deaths to overall mortality in resource-limited settings is small and TB-IRD is not undermining ART programme outcomes (Lawn et al. 2007; Castelnuovo et al. 2009).”
BackgroundSelf-citationYiannoutsos, C. T. (2009) · Journal of the International AIDS Society · doi:10.1186/1758-2652-12-9 · Cited by 17
The impact of HAART initiation timing on HIV-TB co-infected patients, a retrospective cohort study
Yang, C.-H., Chen, K.-J., Tsai, J., Lin, Y., Cheng, S., Wang, K. F., & Chiou, H. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-304 · Cited by 17
“Nevertheless, early initiation of HAART during TB treatment is strongly associated with the occurrence of IRIS [8,9].”
BackgroundYang, C.-H., Chan, P.-C., Liao, S.-T., Cheng, S., Wong, W. W., Huang, L., Hsueh, P., & Chiou, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073069 · Cited by 17
“HIV-infected individuals have a higher rate of progression from latent tuberculosis infection (LTBI) to active TB than do nonHIV-infected persons, even with the use of effective antiretroviral therapy and the relative risk reached ten-fold [1,2,3,4].”
BackgroundOptimum Time to Initiate Antiretroviral Therapy in Patients With HIV-Associated Tuberculosis
Lawn, S. D., & Wood, R. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181398d28 · Cited by 17
Self-citationOgola, G. O., Ouma, C., Jura, W. G. Z. O., Muok, E. M. O., Colebunders, R., & Mwinzi, P. N. M. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-316 · Cited by 18
“IRIS is characterized by acute inflammatory responses to chronic opportunistic infections such as schistosomias, and is accompanied by a state of immunosuppression, with the immune system beginning to recover with a response to a previously acquired opportunistic infection which results in a heightened inflammatory re…”
BackgroundMeintjes, G., & Sonderup, M. W. (2011) · CME/Continuing medical education · Cited by 15
Kumarasamy, N., Venkatesh, K. K., Vignesh, R., Devaleenal, B., Poongulali, S., Yepthomi, T., Flanigan, T., Benson, C. A., & Mayer, K. H. (2012) · Journal of the International Association of Providers of AIDS Care (JIAPAC) · doi:10.1177/1545109712457711 · Cited by 18
“Patients diagnosed with IRIS have been shown to initiate HAART in closer proximity to the diagnosis of their opportunistic infection compared to patients who did not develop IRIS.(5,8) However, the current study did not document this temporal difference in HAART initiation and diagnosis of opportunistic infection betw…”
ResultTwigg, H. L., & Knox, K. S. (2007) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2007.11.001 · Cited by 16
“Predictors of IRIS are few, but it appears that a low CD4 nadir, CD4 T cell increase after one month of therapy, rate of decrease in HIV RNA levels, CD8 T cell numbers and previous opportunistic infections all may play a role [46,53-55].”
BackgroundChiang, S. S., & Starke, J. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00134-1 · Cited by 17
Kumar, S., Narendran, G., Patrawalla, P. S., Menon, P. A., Mayer, K. H., & Swaminathan, S. (2012) · International Journal of STD & AIDS · doi:10.1258/ijsa.2009.009439 · Cited by 15
Reyes‐Corcho, A., & Bouza‐Jiménez, Y. (2009) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2009.03.007 · Cited by 23
Bronchial asthma on Mount Kilimanjaro is not a disadvantage
Stokes, S., Kalson, N. S., Earl, M., Frost, H., Whitehead, A. G., Tyrrell-Marsh, I., & Davies, A. (2008) · Thorax · doi:10.1136/thx.2008.102327 · Cited by 15
Rivero, A., Pulido, F., Caylà, J. A., Iribarren, J. A., Miró, J. M., Moreno, S., & Camacho, I. P. (2013) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2013.02.001 · Cited by 14
Stek, C. J., Schutz, C., Blumenthal, L., Thienemann, F., Buyze, J., Nöstlinger, C., Ravinetto, R., Wouters, E., Colebunders, R., Maartens, G., et al. (2016) · JMIR Research Protocols · doi:10.2196/resprot.6046 · Cited by 14
“However, the incidence is substantially higher in patients with a CD4 count ≤ 100/μL starting ART within 30 days of TB treatment because these are two major risk factors [2,29].”
Török, M. E., Aljayyoussi, G., Waterhouse, D., Tth., C., Nth., M., Phu, N., Hien, T. T., Hope, W. W., Farrar, J., & Ward, S. A. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.646 · Cited by 14
“drug–drug interactions, which could in turn lead to adverse effects such as IRIS (increased immune reconstitution inflammatory syndrome).(7) Conversely, early initiation of ART has been positively correlated with AIDS-free survival in patients with HIV-associated TB.”
BackgroundImmune Reconstitution Inflammatory Syndrome Presenting as Pericarditis and Pericardial Effusion
Rapose, A., Sarvat, B., & Sarria, J. C. (2007) · Cardiology · doi:10.1159/000110494 · Cited by 16
Kilborn, T., & Zampoli, M. (2009) · Pediatric Radiology · doi:10.1007/s00247-009-1192-y · Cited by 13
“There is a greater incidence of IRIS in patients with severe immunosuppression at the time of commencing HAART [8, 11, 12].”
BackgroundKerkhoff, A. D., Wood, R., & Lawn, S. D. (2011) · AIDS · doi:10.1097/qad.0b013e328345ee32 · Cited by 13
Self-citationConfronting TB/HIV in the era of increasing anti‐TB drug resistance
Chakaya, J. M., Getahun, H., Granich, R., & Havlir, D. V. (2008) · Journal of the International AIDS Society · doi:10.1186/1758-2652-11-6 · Cited by 13
“However early initiation of ART within the first one month of anti-TB treatment may be a risk factor for TBIRIS [26].”
Metadata
- Authors
- Lawn, S. D., Myer, L., Bekker, L.-G., & Wood, R.
- Affiliations
- University of Cape Town (ZA)
- Corresponding author
- Lawn, Stephen D
- Venue
- AIDS
- Published
- 2007-01-30
- Volume
- 21
- Issue
- 3
- Pages
- 335-341
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W2020198464
- Cited by
- 343
- References
- 27
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 3 · 2022: 1 · 2021: 8 · 2020: 4 · 2019: 7 · 2018: 9 · 2017: 10 · 2016: 8 · 2015: 12 · 2014: 16 · 2013: 31 · 2012: 25
- FWCI
- 51.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- AIDS (publishedVersion)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
- Funders
- Wellcome Trust (074641)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- National Institute of Allergy and Infectious Diseases (1U19 AI53217-01, AI 058736-01A1, U19AI053217, R01AI058736)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Keywords
- tuberculosis, antiretroviral therapy, CD4 count, early ART initiation, risk factors, pulmonary tuberculosis, South Africa
- MeSH terms
- Adult, Antitubercular Agents, Developing Countries, Epidemiologic Methods, Female, Humans, Immune System Diseases, Inflammation, Male, South Africa, Tuberculosis, HIV Infections, AIDS-Related Opportunistic Infections, CD4 Lymphocyte Count, Anti-HIV Agents, Antiretroviral Therapy, Highly Active
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.